Women’s Health Therapeutics Market Size to Reach USD 61.6 Billion by 2032, Driven by Rising Awareness & Technological Advancements - SNS Insider
October 15, 2024 09:10 ET
|
SNS Insider pvt ltd
Pune, Oct. 15, 2024 (GLOBE NEWSWIRE) -- According to SNS Insider, The Women’s Health Therapeutics Market was estimated to be USD 43.21 billion in 2023 and is projected to be valued at USD 61.6...
AIM ImmunoTech Granted U.S. Patent for Ampligen® for the Treatment of Endometriosis
October 03, 2024 08:45 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., Oct. 03, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that the United States Patent and Trademark Office (USPTO) has...
U.S. Women's Health Market Size, Share & Trends Analysis Report 2024-2030: Hormonal Infertility, Contraceptives, Postmenopausal Osteoporosis, Endometriosis & Uterine Fibroids, Menopause, PCOS
September 20, 2024 04:04 ET
|
Research and Markets
Dublin, Sept. 20, 2024 (GLOBE NEWSWIRE) -- The "U.S. Women's Health Market Size, Share & Trends Analysis Report By Application (Contraceptives, Endometriosis & Uterine Fibroids), By Age (50...
United States Endometriosis and Uterine Fibroids Markets, 2020-2024 & 2025-2030: Rise in Non-Invasive Drug Therapies Driving Growth, Online Pharmacies Set to Revolutionize Distribution
September 19, 2024 07:25 ET
|
Research and Markets
Dublin, Sept. 19, 2024 (GLOBE NEWSWIRE) -- The "United States Endometriosis and Uterine Fibroids Market (2024 Edition): Analysis By Drug Type, By Route of Administration, By Distribution Channel, By...
Women's Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030) Featuring Profiles of Amgen, Teva Pharma, Merck & Co, Bayer, AbbVie
September 18, 2024 04:14 ET
|
Research and Markets
Dublin, Sept. 18, 2024 (GLOBE NEWSWIRE) -- The "Women Reproductive Health Market (2024 Edition): Market Insights and Forecast (2020-2030)" report has been added to ResearchAndMarkets.com's...
Endometriosis Drug Pipeline Landscape 2024: Insights About 15+ Companies and 20+ Pipeline Drugs
June 17, 2024 06:54 ET
|
Research and Markets
Dublin, June 17, 2024 (GLOBE NEWSWIRE) -- The "Endometriosis - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
Ovarian Cancer Pipeline Drugs Analysis, 2024: Insights on 180+ Companies and 200+ Pipeline Drugs, Including Atezolizumab (Genentech), Tisotuma Vedotin (Genmab), and SON-1010 (Sonnet Biotherapeutics)
June 10, 2024 10:11 ET
|
Research and Markets
Dublin, June 10, 2024 (GLOBE NEWSWIRE) -- The "Ovarian Cancer - Pipeline Insight, 2024" clinical trials has been added to ResearchAndMarkets.com's offering.This report provides comprehensive...
National Poll Shows Women Are Missing Out on Vacations, Work, and Social Events Due to Gynecological Conditions
May 02, 2024 10:00 ET
|
LevLane
PHILADELPHIA, May 02, 2024 (GLOBE NEWSWIRE) -- LevLane Advertising, one of Philadelphia's oldest independent full-service advertising agencies, today released the findings of a women's health survey...
Gynecological Devices Market Analysis 2024-2033: Robotic Surgery, AI Diagnostics, and Minimally Invasive Procedures Reshape the $12.44 Billion Industry
January 24, 2024 13:48 ET
|
Research and Markets
Dublin, Jan. 24, 2024 (GLOBE NEWSWIRE) -- The "Gynecological Devices Global Market Report 2024" report has been added to ResearchAndMarkets.com's offering. Global Gynecological Devices Market...
Global $67B+ Women's Health Market Landscape 2024-2030: Analysis by Age, Application and Region
January 11, 2024 12:43 ET
|
Research and Markets
Dublin, Jan. 11, 2024 (GLOBE NEWSWIRE) -- The "Global Women's Health Market Size, Share & Trends Analysis Report by Application (Postmenopausal Osteoporosis, Infertility, Endometriosis &...